Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 50, 2006, Pages 19057-19062

  Zhou, Dun ^a   Srivastava, Rajneesh ^a   Nessler, Stefan ^a   Grummel, Verena ^a   Sommer, Norbert ^b   Brück, Wolfgang ^c   Hartung, Hans Peter ^a   Stadelmann, Christine ^c   Hemmer, Bernhard ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Antibodies; Axonal damage; Demyelination; Lentiviral expression

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; AUTOANTIBODY; MYELIN ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; RECOMBINANT PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BIOASSAY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DEMYELINATION; FEMALE; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; WHITE MATTER; ANIMAL; BLOOD; GENETICS; GLIOMA; IMMUNOLOGY; METABOLISM; MYELIN SHEATH; PATHOLOGY;

ANIMALIA; RATTUS;

ANIMALS; AUTOANTIBODIES; GLIOMA; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; RATS; RECOMBINANT PROTEINS;

EID: 33847180757     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0607242103     Document Type: Article

References (38)

1. Steinman L (2001) Nat Immunol 2:762-764.
2. Lassmann H, Raine CS, Antel J, Prineas JW (1998) J Neuroimmunol 86:213-217.
3. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Ann Neurol 47:707-717.
4. Hemmer B, Archelos JJ, Hartung HP (2002) Nat Rev Neurosci 3:291-301.
5. Martin R, McFarland HF, McFarlin DE (1992) Annu Rev Immunol 10:153-187.
6. Johns TG, Bernard CC (1999) J Neurochem 72:1-9.
7. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C (1989) J Neurochem 52:296-304.
8. Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu HC, Lassmann H, Wekerle H (1993) Eur J Immunol 23:1364-1372.
9. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu JM, Baker D (1994) J Immunol 153:4349-4356.
10. Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu JM, Gardinier MV, Dornmair K, Linington C (1995) J Neuroimmunol 63:17-27.
11. Weissert R, Wallstrom E, Storch MK, Stefferl A, Lorentzen J, Lassmann H, Linington C, Olsson T (1998) J Clin Invest 102:1265-1273.
12. Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M, Lees MB, Linington C, Hauser SL (1995) J Clin Invest 96:2966-2974.
13. Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Am J Pathol 130:443-454.
14. Bourquin C, Iglesias A, Berger T, Wekerle H, Linington C (2000) Eur J Immunol 30:3663-3671.
15. von Budingen HC, Tanuma N, Villoslada P, Ouallet JC, Hauser SL, Genain CP (2001) J Clin Immunol 21:155-170.
16. Piddlesden SJ, Lassmann H, Zimprich F, Morgan BP, Linington C (1993) Am J Pathol 143:555-564.
17. Marta CB, Oliver AR, Sweet RA, Pfeiffer SE, Ruddle NH (2005) Proc Natl Acad Sci USA 102:13992-13997.
18. Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C (2001) Glia 36:220-234.
19. Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, Dilitz E, Deisenhammer F, Reindl M (2003) N Engl J Med 349:139-145.
20. Rauer S, Euler B, Reindl M, Berger T (2006) J Neurol Neurosurg Psychiatry 77:739-742.
21. Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T (1999) Brain 122:2047-2056.
22. Lampasona V, Franciotta D, Furlan R, Zanaboni S, Fazio R, Bonifacio E, Comi G, Martino G (2004) Neurology 62:2092-2094.
23. O'Connor KC, Appel H, Bregoli L, Call ME, Catz I, Chan JA, Moore NH, Warren KG, Wong SJ, Hafler DA, et al. (2005) J Immunol 175:1974-1982.
24. Genain CP, Cannella B, Hauser SL, Raine CS (1999) Nat Med 5:170-175.
25. Haase CG, Guggenmos J, Brehm U, Andersson M, Olsson T, Reindl M, Schneidewind JM, Zettl UK, Heidenreich F, Berger T, et al. (2001) J Neuroimmunol 114:220-225.
26. Lalive PH, Menge T, Delarasse C, Della GB, Pham-Dinh D, Villoslada P, von Budingen HC, Genain CP (2006) Proc Natl Acad Sci USA 103:2280-2285.
27. Linnington C, Webb M, Woodhams PL (1984) J Neuroimmunol 6:387-396.
28. Slavin AJ, Johns TG, Orian JM, Bernard CC (1997) Dev Neurosci 19:69-78.
29. Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, et al. (1999) Nat Genet 23:343-347.
30. Cross AH, Trotter JL, Lyons J (2001) J Neuroimmunol 112:1-14.
31. Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, et al. (2005) Lancet 366:579-582.
32. Vincent A (2002) Nat Rev Immunol 2:797-804.
33. Rose NR, Bona C (1993) Immunol Today 14:426-430.
34. Monson NL, Cravens PD, Frohman EM, Hawker K, Racke MK (2005) Arch Neurol 62:258-264.
35. Stuve O, Cepok S, Elias B, Saleh A, Hartung HP, Hemmer B, Kieseier BC (2005) Arch Neurol 62:1620-1623.
36. Diserens AC, de Tribolet N, Martin-Achard A, Gaide AC, Schnegg JF, Carrel S (1981) Acta Neuropathol (Berlin) 53:21-28.
37. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) Lancet 364:2106-2112.
38. Weissert R, Svenningsson A, Lobell A, de Graaf KL, Andersson R, Olsson T (1998) J Immunol 160:681-690.